APA aipamena

Tibes, R., Borad, M. J., Dutcus, C. E., Reyderman, L., Feit, K., Eisen, A., . . . Von Hoff, D. D. (2018). Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: Results of a phase 1 study. Br J Cancer.

Chicago Style aipamena

Tibes, Raoul, Mitesh J. Borad, Corina E. Dutcus, Larisa Reyderman, Kevie Feit, Andrew Eisen, David A. Verbel, and Daniel D. Von Hoff. "Safety, Pharmacokinetics, and Preliminary Efficacy of E6201 in Patients With Advanced Solid Tumours, Including Melanoma: Results of a Phase 1 Study." Br J Cancer 2018.

MLA aipamena

Tibes, Raoul, et al. "Safety, Pharmacokinetics, and Preliminary Efficacy of E6201 in Patients With Advanced Solid Tumours, Including Melanoma: Results of a Phase 1 Study." Br J Cancer 2018.